Abstract
Isoxsuprine, an agent of known vasodilator effectiveness, was shown to be a potent inhibitor of various types of smooth muscle. In vitro, it was similar to papaverine in many respects. The most outstanding differences were its lesser ability to antagonize acetylcholine and to inhibit intestinal smooth muscle, and its greater potency in antagonizing l-norepinephrine and oxytocin. In vivo, isoxsuprine had a relatively long duration of action and inhibited every type of smooth muscle tested. Results suggested that isoxsuprine has the highest degree of inhibitory activity against uterine and biliary muscle, and that it has the lowest activity against intestinal smooth muscle. Intermediate activity was observed on respiratory and ureteral smooth muscle. Concepts suggestive of the mechanism of action are discussed.
Footnotes
- Received November 3, 1959.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|